Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 5/2020

01-05-2020 | Mood Disorders | Concise Research Report

Willingness to Engage in Traditional and Novel Depression Treatment Modalities Among Myocardial Infarction Survivors

Authors: Nathalie Moise, MD, MS, Anusorn Thanataveerat, MPH, Ludwing Florez-Salamanca, MD, Siqin Ye, MD, MS, Min Qian, PhD, Megan Obi, BA, Carmela Alcantara, PhD

Published in: Journal of General Internal Medicine | Issue 5/2020

Login to get access

Excerpt

Depression is a known risk factor for morbidity and mortality following myocardial infarction (MI).1 Several groups, including the American Heart Association, recommend depression screening and treatment post-MI.2 Yet, fewer post-MI survivors receive depression treatment than general depressed populations.3 To inform implementation efforts, we assessed depression treatment attitudes, acceptability, and willingness (by modality) among MI survivors with elevated depressive symptoms. …
Literature
1.
Lett HS, Blumenthal JA, Babyak MA, et al. Depression as a Risk Factor for Coronary Artery Disease: Evidence, Mechanisms, and Treatment. Psychosom Med. 2004;66(3):305–315.PubMed
2.
Lichtman JH, Bigger JT, Blumenthal JA, et al. Depression and Coronary Heart Disease: Recommendations for Screening, Referral, and Treatment: A Science Advisory From the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Psychiatric Association. Circulation. 2008;118(17):1768–1775.CrossRef
3.
Smolderen KG, Spertus JA, Gosch K, et al. Depression Treatment and Health Status Outcomes in Young Patients With Acute Myocardial Infarction: Insights From the VIRGO Study (Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients). Circulation. 2017;135(18):1762–1764.CrossRef
4.
Van Voorhees BW, Cooper LA, Rost KM, Nutting P, Rubenstein LV, Meredith L, Wang NY and Ford DE. Primary care patients with depression are less accepting of treatment than those seen by mental health specialists. J Gen Intern Med. 2003;18:991–1000.CrossRef
5.
6.
Leng S, MacDougall M and McKinstry B. The acceptability to patients of video-consulting in general practice: semi-structured interviews in three diverse general practices. J Innov Health Inform. 2016;23:141.CrossRef
Metadata
Title
Willingness to Engage in Traditional and Novel Depression Treatment Modalities Among Myocardial Infarction Survivors
Authors
Nathalie Moise, MD, MS
Anusorn Thanataveerat, MPH
Ludwing Florez-Salamanca, MD
Siqin Ye, MD, MS
Min Qian, PhD
Megan Obi, BA
Carmela Alcantara, PhD
Publication date
01-05-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 5/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05406-8

Other articles of this Issue 5/2020

Journal of General Internal Medicine 5/2020 Go to the issue

Concise Research Report

Flipping the Visit: Impact of Blood Pressure Remeasurement after the Visit

Original Research

Preventing Hospital Readmissions: Healthcare Providers’ Perspectives on “Impactibility” Beyond EHR 30-Day Readmission Risk Prediction

Original Research

Interprofessional Collaboration Improves the Odds of Educating Patients About PrEP over Time

Capsule Commentary

Capsule Commentary for Rogers et al., Patients’ Attitudes and Perceptions Regarding Social Needs Screening and Navigation: Multi-Site Survey in a Large Integrated Health System

Review Article

Patient Outcomes Following Interhospital Care Fragmentation: A Systematic Review

Capsule Commentary

Capsule Commentary on Rinne et al., National Burnout Trends Among Physicians Working in the Department of Veterans Affairs
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits